Biomimetic selenium nanomedicine with homologous targeting enhances hepatocellular carcinoma therapy
{{output}}
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with limited effective therapeutic options. While trace elements like selenium (Se)-based nanoparticles (SeNPs) show promising anti-tumor effects, their clinical application is greatly hindered b... ...
